Tirzepatide Microdose Program

Stay on track with once-weekly support. This injectable is ideal for those already stabilized on GLP-1s, helping maintain your progress, ease side effects, and support overall wellness and inflammation response. Tirzepatide is a dual-action GLP-1 and GIP receptor agonist known for its ability to support metabolic function, improve blood sugar regulation, and promote balanced appetite signaling. Not everyone needs or wants the full clinical dose to experience benefits. Our microdosing subscription is designed to deliver the metabolic and anti-inflammatory benefits of Tirzepatide with a gentler, lower-dose approach—ideal for those seeking maintenance, improved metabolic flexibility, or a smoother introduction to GIP/GLP-1 therapy. With consistent delivery, clinical oversight, and a structured protocol, this plan supports metabolic balance without overwhelming your system. Benefits may include: Subtle appetite reduction and mindful eating habits Steady, sustainable weight loss Improved insulin sensitivity and glucose balance Fewer side effects, smoother adaptation period Whether you’re easing into GLP-1 therapy or looking to maintain momentum with minimal disruption, our microdosed Tirzepatide plan supports your goals with precision and care. Go gently. Progress steadily. Tirzepatide Micro-dose Available doses: 2.5mg weekly